The drug rapamycin is being studied for its antiaging and fertility-preserving benefits — and the results seem promising.

In a comprehensive Genomic Press Interview, distinguished psychiatrist Professor Peter Falkai suggests promising new ...

Almirall, a global pharmaceutical company dedicated to medical dermatology, today announced the launch of "The Hive", a novel scientific research hub located at its R&D centre in Barcelona, Spain. The ...

The perspectives and priorities of people living with chronic obstructive pulmonary disease (COPD) should be integrated into ...

A more precise risk calculation would benefit diabetes screening programs that have become more common in the United States ...

The theme at SBM this week is questions for Trump's nominees for key health positions within the federal government. David ...

Digitalisation and AI in Orthopedic Surgery and Rehabilitation 4.0', and the rapidly evolving subject area, we are pleased to ...

"ShiraTronics commences chronic migraine therapy trial" was originally created and published by Medical Device Network, a ...

Oncology drug development, approval, and access represent a rapidly evolving field that faces numerous challenges. The ...

By collecting data from four different antenna orientations post-surgery, researchers are detecting significantly more detailed information on breast cancer than a traditional single-orientation scan ...

Tribe Clinical Research in Greenville has announced the launch of a new trial for a drug centered around Alzheimer's ...

Breast, bladder, and pancreatic cancers are increasingly being treated with a broad range of therapies before a patient undergoes surgery, and cancer stage at diagnosis continues to be a leading ...